Studies of ZHOU Qi and HU Baoyangshowed that implanted human embryonic stem cell-derived neurons survived for two years and further matured. There was no immune rejection or other serious adverse reaction. Apparent behavioral improvement were observed in most monkey models. Clinical experiments in humans are now considered as a next step.
CAS news release, June 19, 2018
Cell therapy of Parkinson’s disease: team at CAS Institute of Zoology use monkey model to evaluate the safety and efficacy of human embryonic stem cell-derived neurons